Literature DB >> 34510730

Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient.

Lawrence J Purpura1,2, Michelle Chang3, Medini K Annavajhala1, Hiroshi Mohri4, Lihong Liu4, Jayesh Shah1, Anyelina Cantos1, Nicola Medrano1, Justin Laracy1, Brian Scully1, Benjamin A Miko1, Marlena Habal5, Marcus R Pereira1, Moriya Tsuji4, David D Ho4, Anne-Catrin Uhlemann1, Michael T Yin1.   

Abstract

Unlike immunocompetent hosts, the duration of viral persistence after infection with severe acute respiratory syndrome coronavirus 2 can be prolonged in immunosuppressed patients. Here, we present a case of viral persistence for over 19 weeks in a patient with a history of solid organ transplant and explore the clinical, virologic, and immunologic course. Our patient still demonstrated viral persistence at 138 days with low polymerase chain reaction cycle threshold values and evidence of continuing viral sequence evolution indicative of ongoing virus replication. These findings have important implications for infection prevention and control recommendations in immunosuppressed patients. Immune response, including neutralizing antibody titers, T cell activity, and cytokine levels, peaked around days 44-72 after diagnosis. Anti-S trimer antibodies were low at all time points, and T cell response was attenuated by day 119. As immune response waned and viral load increased, increased genetic diversity emerged, suggesting a mechanism for the development of viral variants.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; basic (laboratory) research/science; clinical research/practice; immune deficiency; infection and infectious agents-viral; infectious disease; molecular biology: single polynucleotide polymorphism

Mesh:

Substances:

Year:  2021        PMID: 34510730      PMCID: PMC8813887          DOI: 10.1111/ajt.16837

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   9.369


  19 in total

1.  Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.

Authors:  Jared Bullard; Kerry Dust; Duane Funk; James E Strong; David Alexander; Lauren Garnett; Carl Boodman; Alexander Bello; Adam Hedley; Zachary Schiffman; Kaylie Doan; Nathalie Bastien; Yan Li; Paul G Van Caeseele; Guillaume Poliquin
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

2.  Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.

Authors:  Marcus R Pereira; Selim Arcasoy; Maryjane A Farr; Sumit Mohan; Jean C Emond; Demetra S Tsapepas; Qiuhu Shi; Lawrence Purpura; Anne-Catrin Uhlemann; Jason Zucker; Elizabeth C Verna
Journal:  Transpl Infect Dis       Date:  2021-05-31

3.  Cycle Thresholds Among Solid Organ Transplant Recipients Testing Positive for SARS-CoV-2.

Authors:  Deborah A Theodore; William G Greendyke; Benjamin Miko; Susan Whittier; Daniel A Green; Sherif Shoucri; Elizabeth C Verna; Jason Zucker; Magdalena E Sobieszczyk; Justin G Aaron; Brian E Scully; Lisa Saiman; Marcus Pereira; E Yoko Furuya
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

4.  Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids.

Authors:  Jiufeng Sun; Jianpeng Xiao; Ruilin Sun; Xi Tang; Chumin Liang; Huifang Lin; Lilian Zeng; Jianxiong Hu; Runyu Yuan; Pingping Zhou; Jinju Peng; Qianlin Xiong; Fengfu Cui; Zhe Liu; Jing Lu; Junzhang Tian; Wenjun Ma; Changwen Ke
Journal:  Emerg Infect Dis       Date:  2020-05-08       Impact factor: 6.883

5.  Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.

Authors:  Siw Johannesen; Bettina Budeus; Sebastian Peters; Sabine Iberl; Anne-Louise Meyer; Tina Kammermaier; Eva Wirkert; Tim-Henrik Bruun; Verena C Samara; Wilhelm Schulte-Mattler; Wolfgang Herr; Armin Schneider; Jochen Grassinger; Ulrich Bogdahn
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

6.  Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

Authors:  Jeroen J A van Kampen; David A M C van de Vijver; Pieter L A Fraaij; Bart L Haagmans; Mart M Lamers; Nisreen Okba; Johannes P C van den Akker; Henrik Endeman; Diederik A M P J Gommers; Jan J Cornelissen; Rogier A S Hoek; Menno M van der Eerden; Dennis A Hesselink; Herold J Metselaar; Annelies Verbon; Jurriaan E M de Steenwinkel; Georgina I Aron; Eric C M van Gorp; Sander van Boheemen; Jolanda C Voermans; Charles A B Boucher; Richard Molenkamp; Marion P G Koopmans; Corine Geurtsvankessel; Annemiek A van der Eijk
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

7.  Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.

Authors:  Bina Choi; Manish C Choudhary; James Regan; Jeffrey A Sparks; Robert F Padera; Xueting Qiu; Isaac H Solomon; Hsiao-Hsuan Kuo; Julie Boucau; Kathryn Bowman; U Das Adhikari; Marisa L Winkler; Alisa A Mueller; Tiffany Y-T Hsu; Michaël Desjardins; Lindsey R Baden; Brian T Chan; Bruce D Walker; Mathias Lichterfeld; Manfred Brigl; Douglas S Kwon; Sanjat Kanjilal; Eugene T Richardson; A Helena Jonsson; Galit Alter; Amy K Barczak; William P Hanage; Xu G Yu; Gaurav D Gaiha; Michael S Seaman; Manuela Cernadas; Jonathan Z Li
Journal:  N Engl J Med       Date:  2020-11-11       Impact factor: 91.245

8.  SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.

Authors:  Pengfei Wang; Lihong Liu; Manoj S Nair; Michael T Yin; Yang Luo; Qian Wang; Ting Yuan; Kanako Mori; Axel Guzman Solis; Masahiro Yamashita; Ankur Garg; Lawrence J Purpura; Justin C Laracy; Jian Yu; Leemor Joshua-Tor; Joseph Sodroski; Yaoxing Huang; David D Ho
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.

Authors:  Jing Lu; Jinju Peng; Qianling Xiong; Zhe Liu; Huifang Lin; Xiaohua Tan; Min Kang; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chumin Liang; Lina Yi; Louis du Plessis; Tie Song; Wenjun Ma; Jiufeng Sun; Oliver G Pybus; Changwen Ke
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

10.  Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.

Authors:  Ji Hoon Baang; Christopher Smith; Carmen Mirabelli; Andrew L Valesano; David M Manthei; Michael A Bachman; Christiane E Wobus; Michael Adams; Laraine Washer; Emily T Martin; Adam S Lauring
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

View more
  1 in total

1.  Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.

Authors:  Jonathan S Hausmann; Julia F Simard; Jeffrey A Sparks; Michael DiIorio; Kevin Kennedy; Jean W Liew; Michael S Putman; Emily Sirotich; Sebastian E Sattui; Gary Foster; Carly Harrison; Maggie J Larché; Mitchell Levine; Tarin T Moni; Lehana Thabane; Suleman Bhana; Wendy Costello; Rebecca Grainger; Pedro M Machado; Philip C Robinson; Paul Sufka; Zachary S Wallace; Jinoos Yazdany; Monique Gore-Massy; Richard A Howard; More A Kodhek; Nadine Lalonde; Laura-Ann Tomasella; John Wallace; Akpabio Akpabio; Deshiré Alpízar-Rodríguez; Richard P Beesley; Francis Berenbaum; Inita Bulina; Eugenia Yupei Chock; Richard Conway; Alí Duarte-García; Eimear Duff; Tamer A Gheita; Elizabeth R Graef; Evelyn Hsieh; Lina El Kibbi; David Fl Liew; Chieh Lo; Michal Nudel; Aman Dev Singh; Jasvinder A Singh; Namrata Singh; Manuel F Ugarte-Gil
Journal:  RMD Open       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.